Semiconductor real-time quality assurance dosimetry in brachytherapy

RIS ID

116808

Publication Details

Carrara, M., Cutajar, D., Alnaghy, S., Espinoza, A., Romanyukha, A., Presilla, S., Tenconi, C., Cerrotta, A., Fallai, C., Safavi-Naeini, M., Petasecca, M., Kejda, A., Lerch, M., Corde, S., Jackson, M., Howie, A., Bucci, J. & Rosenfeld, A. B. (2018). Semiconductor real-time quality assurance dosimetry in brachytherapy. Brachytherapy, 17 (1), 133-145.

Abstract

With the increase in complexity of brachytherapy treatments, there has been a demand for the development of sophisticated devices for delivery verification. The Centre for Medical Radiation Physics (CMRP), University of Wollongong, has demonstrated the applicability of semiconductor devices to provide cost-effective real-time quality assurance for a wide range of brachytherapy treatment modalities. Semiconductor devices have shown great promise to the future of pretreatment and in vivo quality assurance in a wide range of brachytherapy treatments, from high-dose-rate (HDR) prostate procedures to eye plaque treatments. The aim of this article is to give an insight into several semiconductor-based dosimetry instruments developed by the CMRP. Applications of these instruments are provided for breast and rectal wall in vivo dosimetry in HDR brachytherapy, urethral in vivo dosimetry in prostate low-dose-rate (LDR) brachytherapy, quality assurance of HDR brachytherapy afterloaders, HDR pretreatment plan verification, and real-time verification of LDR and HDR source dwell positions.

Please refer to publisher version or contact your library.

Share

COinS
 

Link to publisher version (DOI)

http://dx.doi.org/10.1016/j.brachy.2017.08.013